Restasis is considered an expensive medication, with a retail price that can be several hundred dollars for a prescription.
What Contributes to the Cost of Restasis?
The high cost of Restasis is influenced by several factors, including the research and development expenses involved in bringing a novel drug to market, manufacturing complexities, and the ongoing costs associated with maintaining regulatory approval and quality standards. Prescription drug pricing in the United States is also influenced by market dynamics and the absence of direct government price negotiation for Medicare Part D [1].
How Does Restasis Pricing Compare to Other Dry Eye Treatments?
When compared to some over-the-counter artificial tears, prescription medications like Restasis are significantly more expensive. However, it is priced similarly to other prescription medications designed to treat chronic or severe dry eye disease, which often target underlying inflammation rather than just providing lubrication [2].
Can Patients Access Lower-Cost Options for Restasis?
Patients may be able to reduce their out-of-pocket costs for Restasis through various patient assistance programs offered by the manufacturer, Allergan (now part of AbbVie). These programs can provide copay cards or financial assistance to eligible individuals who have commercial insurance [3]. For those without insurance, other options might include exploring generic alternatives if they become available or discussing cost-effective treatment plans with their healthcare provider.
When Does Restasis's Market Exclusivity End?
Restasis has faced numerous patent challenges, which could influence its market exclusivity and the potential for generic competition. DrugPatentWatch.com tracks these patent expirations and legal challenges, indicating that various patents related to Restasis have faced litigation and their expiration dates have been a point of contention [4]. The entry of generic versions of Restasis, when legally permissible after patent expirations, could lead to lower prices.